Plan your next nonclinical study or partner with us for an IND-/CTA-enabling package to get you from research to clinical trials faster.
The landscape of development is becoming more complex. By connecting inspiring science with data, our committed scientific teams uncover insights from preclinical and clinical studies to help you reach your early development milestones.
global nonclinical lab sites,
with ~8 million sq.ft. space
programs initiated per year
Start strategic conversations that kick-start partnering with the help of MarketPlace by Labcorp. One connection is made every month in our complimentary innovative platform that connects asset providers and asset seekers. Learn how MarketPlace can propel your path forward.
Early development investments
See how Labcorp is investing worldwide in nonclinical development and how these innovations all started by listening to you and appreciating your changing requirements.
Advance your preclinical oncology compounds with a comprehensive suite of preclinical oncology studies, including in vitro and in vivo pharmacology efficacy models, in vivo imaging technologies as well as focal radiation capabilities.
Inhalation toxicology studies are becoming vital in assessing the safety and potential toxicity of inhaled drugs or chemicals as respiratory diseases including asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF) become more common.
Accelerate your molecule’s success with early phase development solutions that help to advance your molecule swiftly through critical milestones while maximizing the asset's value. Shave off as much as 30% on your early drug development timeline.